MedPath

Dronapushpi (Leucas cephalotes Roth) arka nebulization in the management of Tamaka Shwasa (Bronchial asthma)

Phase 2
Conditions
Health Condition 1: J452- Mild intermittent asthmaHealth Condition 2: J452- Mild intermittent asthma
Registration Number
CTRI/2019/11/022081
Lead Sponsor
Dr Medha B Bhat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Conscious and well oriented

Age 18-60yrs

Either gender

Previously diagnosed case of bronchial asthma

Exclusion Criteria

Subjects with a history of tuberculosis, emphysema, chronic airway limitation

History of cardiac involvement

Other complicated respiratory diseases having any organic lesions such as tumor or any anatomical defect in the airway.

Cyanosis

Hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of Dronapushpi Arka Nebulisation in the management of Tamaka Shwasa(Bronchial asthma)Timepoint: Assessment will be done on Borderline and for every 15 minutes for 1 hour
Secondary Outcome Measures
NameTimeMethod
Quality of LifeTimepoint: Assessment will be done on Borderline and for Every 15 Minutes for 1 Hour
© Copyright 2025. All Rights Reserved by MedPath